Logo image of NHI

NATL HEALTH INVESTORS INC (NHI) Stock Fundamental Analysis

NYSE:NHI - New York Stock Exchange, Inc. - US63633D1046 - REIT - Currency: USD

75.77  +0.46 (+0.61%)

After market: 75.77 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NHI. NHI was compared to 130 industry peers in the Diversified REITs industry. While NHI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, NHI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NHI had positive earnings in the past year.
In the past year NHI had a positive cash flow from operations.
In the past 5 years NHI has always been profitable.
Each year in the past 5 years NHI had a positive operating cash flow.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With an excellent Return On Assets value of 5.27%, NHI belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
The Return On Equity of NHI (10.09%) is better than 87.69% of its industry peers.
NHI has a Return On Invested Capital of 5.87%. This is amongst the best in the industry. NHI outperforms 93.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NHI is above the industry average of 3.20%.
The last Return On Invested Capital (5.87%) for NHI is above the 3 year average (5.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.27%
ROE 10.09%
ROIC 5.87%
ROA(3y)4.46%
ROA(5y)4.65%
ROE(3y)8.71%
ROE(5y)9.16%
ROIC(3y)5.45%
ROIC(5y)5.5%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

NHI's Profit Margin of 41.13% is amongst the best of the industry. NHI outperforms 90.77% of its industry peers.
NHI's Profit Margin has declined in the last couple of years.
The Operating Margin of NHI (56.24%) is better than 95.38% of its industry peers.
In the last couple of years the Operating Margin of NHI has declined.
NHI has a better Gross Margin (84.06%) than 85.38% of its industry peers.
NHI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 56.24%
PM (TTM) 41.13%
GM 84.06%
OM growth 3Y-3.37%
OM growth 5Y-4.05%
PM growth 3Y3.19%
PM growth 5Y-4%
GM growth 3Y-4.37%
GM growth 5Y-3.06%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

NHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NHI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NHI has been increased compared to 5 years ago.
Compared to 1 year ago, NHI has an improved debt to assets ratio.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.89 indicates that NHI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.89, NHI belongs to the top of the industry, outperforming 95.38% of the companies in the same industry.
The Debt to FCF ratio of NHI is 17.48, which is on the high side as it means it would take NHI, 17.48 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NHI (17.48) is better than 79.23% of its industry peers.
NHI has a Debt/Equity ratio of 0.84. This is a neutral value indicating NHI is somewhat dependend on debt financing.
NHI's Debt to Equity ratio of 0.84 is fine compared to the rest of the industry. NHI outperforms 68.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.48
Altman-Z 1.89
ROIC/WACC0.76
WACC7.73%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.49 indicates that NHI should not have too much problems paying its short term obligations.
NHI's Current ratio of 1.49 is fine compared to the rest of the industry. NHI outperforms 64.62% of its industry peers.
NHI has a Quick Ratio of 1.49. This is a normal value and indicates that NHI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NHI (1.49) is better than 65.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

4

3. Growth

3.1 Past

The earnings per share for NHI have decreased by -4.79% in the last year.
Measured over the past years, NHI shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.49% on average per year.
The Revenue has been growing slightly by 4.80% in the past year.
NHI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.05% yearly.
EPS 1Y (TTM)-4.79%
EPS 3Y6.89%
EPS 5Y-4.49%
EPS Q2Q%9.46%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y3.92%
Revenue growth 5Y1.05%
Sales Q2Q%7.91%

3.2 Future

The Earnings Per Share is expected to grow by 4.12% on average over the next years.
Based on estimates for the next years, NHI will show a quite strong growth in Revenue. The Revenue will grow by 19.04% on average per year.
EPS Next Y6.08%
EPS Next 2Y5.92%
EPS Next 3Y4.12%
EPS Next 5YN/A
Revenue Next Year10.27%
Revenue Next 2Y11.35%
Revenue Next 3Y10.66%
Revenue Next 5Y19.04%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

NHI is valuated quite expensively with a Price/Earnings ratio of 25.43.
NHI's Price/Earnings ratio is a bit cheaper when compared to the industry. NHI is cheaper than 69.23% of the companies in the same industry.
NHI is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 23.97, the valuation of NHI can be described as rather expensive.
Based on the Price/Forward Earnings ratio, NHI is valued cheaply inside the industry as 83.85% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NHI to the average of the S&P500 Index (21.08), we can say NHI is valued inline with the index average.
Industry RankSector Rank
PE 25.43
Fwd PE 23.97
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

NHI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NHI is more expensive than 78.46% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as NHI.
Industry RankSector Rank
P/FCF 53.95
EV/EBITDA 17.93
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NHI does not grow enough to justify the current Price/Earnings ratio.
NHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.18
PEG (5Y)N/A
EPS Next 2Y5.92%
EPS Next 3Y4.12%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.75%, NHI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 28.61, NHI has a dividend in line with its industry peers.
NHI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.52.
Industry RankSector Rank
Dividend Yield 4.75%

5.2 History

The dividend of NHI decreases each year by -3.12%.
NHI has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of NHI decreased in the last 3 years.
Dividend Growth(5Y)-3.12%
Div Incr Years0
Div Non Decr Years2
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

113.52% of the earnings are spent on dividend by NHI. This is not a sustainable payout ratio.
DP113.52%
EPS Next 2Y5.92%
EPS Next 3Y4.12%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

NATL HEALTH INVESTORS INC

NYSE:NHI (4/17/2025, 8:04:00 PM)

After market: 75.77 0 (0%)

75.77

+0.46 (+0.61%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25 2025-02-25/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners71%
Inst Owner Change0%
Ins Owners1.94%
Ins Owner Change4.46%
Market Cap3.54B
Analysts76.67
Price Target83.79 (10.58%)
Short Float %4.75%
Short Ratio9.56
Dividend
Industry RankSector Rank
Dividend Yield 4.75%
Yearly Dividend3.51
Dividend Growth(5Y)-3.12%
DP113.52%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31 2025-03-31 (0.9)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.72%
Min EPS beat(2)-12.08%
Max EPS beat(2)6.65%
EPS beat(4)3
Avg EPS beat(4)1.84%
Min EPS beat(4)-12.08%
Max EPS beat(4)9.11%
EPS beat(8)5
Avg EPS beat(8)4.14%
EPS beat(12)6
Avg EPS beat(12)-14.09%
EPS beat(16)6
Avg EPS beat(16)-19.94%
Revenue beat(2)2
Avg Revenue beat(2)3.84%
Min Revenue beat(2)3.52%
Max Revenue beat(2)4.16%
Revenue beat(4)4
Avg Revenue beat(4)4.03%
Min Revenue beat(4)3.42%
Max Revenue beat(4)5.02%
Revenue beat(8)7
Avg Revenue beat(8)2.59%
Revenue beat(12)8
Avg Revenue beat(12)-0.91%
Revenue beat(16)9
Avg Revenue beat(16)-0.9%
PT rev (1m)3.6%
PT rev (3m)-1.54%
EPS NQ rev (1m)-2.23%
EPS NQ rev (3m)-2.23%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-2.03%
Revenue NQ rev (3m)-3.28%
Revenue NY rev (1m)-4.03%
Revenue NY rev (3m)-4.03%
Valuation
Industry RankSector Rank
PE 25.43
Fwd PE 23.97
P/S 10.55
P/FCF 53.95
P/OCF 17.03
P/B 2.59
P/tB 2.59
EV/EBITDA 17.93
EPS(TTM)2.98
EY3.93%
EPS(NY)3.16
Fwd EY4.17%
FCF(TTM)1.4
FCFY1.85%
OCF(TTM)4.45
OCFY5.87%
SpS7.18
BVpS29.27
TBVpS29.27
PEG (NY)4.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.27%
ROE 10.09%
ROCE 7.43%
ROIC 5.87%
ROICexc 5.93%
ROICexgc 5.96%
OM 56.24%
PM (TTM) 41.13%
GM 84.06%
FCFM 19.56%
ROA(3y)4.46%
ROA(5y)4.65%
ROE(3y)8.71%
ROE(5y)9.16%
ROIC(3y)5.45%
ROIC(5y)5.5%
ROICexc(3y)5.5%
ROICexc(5y)5.56%
ROICexgc(3y)5.53%
ROICexgc(5y)5.6%
ROCE(3y)6.9%
ROCE(5y)6.97%
ROICexcg growth 3Y3.22%
ROICexcg growth 5Y0.14%
ROICexc growth 3Y3.22%
ROICexc growth 5Y0.15%
OM growth 3Y-3.37%
OM growth 5Y-4.05%
PM growth 3Y3.19%
PM growth 5Y-4%
GM growth 3Y-4.37%
GM growth 5Y-3.06%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.48
Debt/EBITDA 4.41
Cap/Depr 199.04%
Cap/Sales 42.42%
Interest Coverage 3.4
Cash Conversion 79.93%
Profit Quality 47.56%
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z 1.89
F-Score5
WACC7.73%
ROIC/WACC0.76
Cap/Depr(3y)89.28%
Cap/Depr(5y)89.91%
Cap/Sales(3y)19.27%
Cap/Sales(5y)20.88%
Profit Quality(3y)140.72%
Profit Quality(5y)127.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.79%
EPS 3Y6.89%
EPS 5Y-4.49%
EPS Q2Q%9.46%
EPS Next Y6.08%
EPS Next 2Y5.92%
EPS Next 3Y4.12%
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y3.92%
Revenue growth 5Y1.05%
Sales Q2Q%7.91%
Revenue Next Year10.27%
Revenue Next 2Y11.35%
Revenue Next 3Y10.66%
Revenue Next 5Y19.04%
EBIT growth 1Y5.6%
EBIT growth 3Y0.41%
EBIT growth 5Y-3.04%
EBIT Next Year55.91%
EBIT Next 3Y17.97%
EBIT Next 5Y11.78%
FCF growth 1Y-54.03%
FCF growth 3Y-26.33%
FCF growth 5Y24.64%
OCF growth 1Y12.64%
OCF growth 3Y-0.5%
OCF growth 5Y-2.92%